STAT3 and Insulin resistance: Addition of SR1 significantly alleviated Kyn-induced insulin resistance as characterized by the increased p-AKTSer473 along with decreased STAT3, p-STAT3Tyr705 (Fig. 4j) and reduced IL-6 secretion (Fig. 4k).